Biosidus étend sa capacité de production de médicaments biologiques et renforce ses capacités d'approvisionnement mondiales en agalsidase bêta

agalsidase betaPositive

AI Analysis

Summary

Biosidus announced the completion of a new bioreactor facility to expand production capacity and strengthen its global supply capabilities for agalsidase beta, a biosimilar medication.

Importance:4/10

Sentiment:

0.60

biosimilarmanufacturingcapacity expansionagalsidase betaArgentina

Read the original article

Published by PR Newswire Pharma on August 27, 2026 10:26 AM

Read Original